Analysis of data from the National Cancer Institute's SEER program revealed that most patients with urothelial carcinoma had a localized tumor (76.7%). The NCCN treatment guidelines recommend complete TURBT as the primary treatment for patients with non–muscle-invasive bladder cancer. Single-dose intravesical chemotherapy within 24 hours (ideally within 6 hours) of TURBT is recommended and may reduce the rate of recurrence. In addition, imaging of the upper tract collecting system is recommended, if not previously performed.
Radical cystectomy forms part of the treatment recommendations for patients with muscle-invasive tumors.
Learn more about treatment guidelines for urothelial carcinoma.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Kyle A. Richards. Fast Five Quiz: Urothelial Carcinoma - Medscape - Aug 13, 2020.
Comments